Corcept Therapeutics presented data from the CATALYST trial at the American Diabetes Association sessions.
1 report, 0 independent
Updated Jun 24
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Corcept Therapeutics presented data from the CATALYST trial at the American Diabetes Association sessions.
Who's involved
What this event is mainly aboutKeep exploring
Part of
The American Diabetes Association held its Scientific Sessions in Chicago on June 25, 2025.Also in this story
- Ambrosia Biosciences presented clinical data at the American Diabetes Association sessions.
- Researchers presented pre-clinical data on combination therapies for MASH at the ADA Scientific Sessions in Chicago.
- Novo Nordisk presented data at the American Diabetes Association Scientific Sessions held in Chicago.
- BioAge presented clinical data at the American Diabetes Association scientific sessions in Chicago.
The entities involved
-
Corcept Therapeutics
American pharmaceutical company
-
American Diabetes Association
U.S.-based nonprofit organization
Related events
Coverage
Newest first; wire copies grouped- Unknown outlet